How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial?

Stefano De Servi; Stefano Savonitto

doi:10.1016/j.ijcard.2011.02.051

How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial?

Stefano De Servi, Stefano Savonitto

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	265-267
Number of pages	3
Journal	International Journal of Cardiology
Volume	149
Issue number	2
DOIs	https://doi.org/10.1016/j.ijcard.2011.02.051
Publication status	Published - Jun 2 2011

Keywords

Acute coronary syndromes
Clopidogrel
Prasugrel
Ticagrelor

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.ijcard.2011.02.051

Cite this

@article{6f2100a780d34fdd8fa49d6c87fd3cd5,

title = "How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial?",

keywords = "Acute coronary syndromes, Clopidogrel, Prasugrel, Ticagrelor",

author = "{De Servi}, Stefano and Stefano Savonitto",

year = "2011",

month = jun,

day = "2",

doi = "10.1016/j.ijcard.2011.02.051",

language = "English",

volume = "149",

pages = "265--267",

journal = "International Journal of Cardiology",

issn = "0167-5273",